The National Academies’ report touches on ethical issues raised by new technologies such as brain organoids and human-animal chimeras, and suggests that current regulatory oversight is sufficient.

Researchers determined that when introduced into damaged mouse or donated human livers, these lab-grown tissues could integrate into bile ducts and function normally.

Using CRISPR to swap an archaic variant of the NOVA1 gene into human stem cells, researchers create organoids with neurodevelopmental differences from those carrying modern DNA.

Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.

The results are a proof-of-concept that the novel coronavirus can replicate in neurons, but it’s too soon to say whether this occurs in people with COVID-19.

By infecting glioblastoma cells but not healthy brain tissue, some form of the virus could serve a therapeutic purpose.

Stem cells from nine snake species respond to tissue culturing techniques previously used only on mouse and human stem cells.

The Stanford University professor helped develop a technique to grow brain organoids from induced pluripotent stem cells.

A new study suggests that growing in a stressful environment prevents “brains-in-a-dish” from growing in the same way as their in vivo counterparts.

Three-dimensional tissue cultures grown from cancer patients’ own tumors can predict responses to the drug irinotecan.

Scientists are devising human-animal hybrids for harvesting human organs, but lab-derived mini-organs are a less ethically fraught solution to meeting the need for transplantation.

After growing in culture for a few months, the mini-brains produced rhythmic neural activity that strengthened over time.

Scientists are devising human-animal hybrids for harvesting human organs, but lab-derived mini-organs are a less ethically fraught solution to meeting the need for transplantation.